Arpelos Biosciences
Arpelos Biosciences is a seed-stage biotechnology company based in Kendall Square, Cambridge, developing multivalent medicines — therapeutics engineered for high potency and selectivity by engaging multiple targets or sites simultaneously. The founding team comprises scientists from UCSF, Penn, Stanford, and MIT spanning computational biology, immunology, and protein engineering, and the company is backed by prominent biotech investors including Wing Venture Capital. Arpelos currently operates as a stealth-stage research company with a single-page web presence and does not publish a public API, developer portal, SDKs, or technical documentation; this profile is maintained in the API Evangelist network as a company identity record awaiting any future developer surface.
Arpelos Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Therapeutics, and Drug Discovery.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API